141 related articles for article (PubMed ID: 37805451)
1. A pretreatment prediction model of grade 3 tumors classed by the IASLC grading system in lung adenocarcinoma.
Wang K; Liu X; Ding Y; Sun S; Li J; Geng H; Xu M; Wang M; Li X; Sun D
BMC Pulm Med; 2023 Oct; 23(1):377. PubMed ID: 37805451
[TBL] [Abstract][Full Text] [Related]
2. Who benefit from adjuvant chemotherapy in stage I lung adenocarcinoma? A multi-dimensional model for candidate selection.
Jiang MQ; Qian LQ; Shen YJ; Fu YY; Feng W; Ding ZP; Han YC; Fu XL
Neoplasia; 2024 Apr; 50():100979. PubMed ID: 38387107
[TBL] [Abstract][Full Text] [Related]
3. Pretreatment prediction of tumour spread through air spaces in clinical stage I non-small-cell lung cancer.
Ding Y; Chen Y; Wen H; Li J; Chen J; Xu M; Geng H; You L; Pan X; Sun D
Eur J Cardiothorac Surg; 2022 Aug; 62(3):. PubMed ID: 35385066
[TBL] [Abstract][Full Text] [Related]
4. High-grade tumor classified by new system is a prognostic predictor in resected lung adenocarcinoma.
Yoshida C; Yokomise H; Ibuki E; Go T; Haba R; Kadota K
Gen Thorac Cardiovasc Surg; 2022 May; 70(5):455-462. PubMed ID: 35050467
[TBL] [Abstract][Full Text] [Related]
5. PET/CT-based deep learning grading signature to optimize surgical decisions for clinical stage I invasive lung adenocarcinoma and biologic basis under its prediction: a multicenter study.
Zhong Y; Cai C; Chen T; Gui H; Chen C; Deng J; Yang M; Yu B; Song Y; Wang T; Chen Y; Shi H; Xie D; Chen C; She Y
Eur J Nucl Med Mol Imaging; 2024 Jan; 51(2):521-534. PubMed ID: 37725128
[TBL] [Abstract][Full Text] [Related]
6. Validation Study of New IASLC Histology Grading System in Stage I Non-Mucinous Adenocarcinoma Comparing With Minimally Invasive Adenocarcinoma.
Woo W; Cha YJ; Kim BJ; Moon DH; Lee S
Clin Lung Cancer; 2022 Nov; 23(7):e435-e442. PubMed ID: 35945128
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathologic and Genotypic Features of Lung Adenocarcinoma Characterized by the International Association for the Study of Lung Cancer Grading System.
Fujikawa R; Muraoka Y; Kashima J; Yoshida Y; Ito K; Watanabe H; Kusumoto M; Watanabe SI; Yatabe Y
J Thorac Oncol; 2022 May; 17(5):700-707. PubMed ID: 35227909
[TBL] [Abstract][Full Text] [Related]
8. The IASLC Proposed Grading System Accurately Predicts Prognosis and Mediastinal Nodal Metastasis in Patients With Clinical Stage I Lung Adenocarcinoma.
Xu L; Su H; Hou L; Wang F; Xie H; She Y; Gao J; Zhao S; Dai C; Xie D; Zhu Y; Wu C; Zhao D; Chen C;
Am J Surg Pathol; 2022 Dec; 46(12):1633-1641. PubMed ID: 36224092
[TBL] [Abstract][Full Text] [Related]
9. Prognosis of resected invasive mucinous adenocarcinoma compared with the IASLC histologic grading system for invasive nonmucinous adenocarcinoma: Surgical database study in the TKIs era in Korea.
Woo W; Yang YH; Cha YJ; Moon DH; Shim HS; Cho A; Kim BJ; Kim HE; Park BJ; Lee JG; Kim DJ; Paik HC; Lee S; Lee CY
Thorac Cancer; 2022 Dec; 13(23):3310-3321. PubMed ID: 36345148
[TBL] [Abstract][Full Text] [Related]
10. Optimised architecture-based grading system as an independent prognostic factor in resected lung adenocarcinoma.
Qiu JH; Hu GM; Zhang RZ; Hu M; Li Z; Zhang Y; Wu HF; Fu WJ; Zhang M; Feng YK; Niu L; Ren JL
J Clin Pathol; 2022 Mar; 75(3):176-184. PubMed ID: 33372106
[TBL] [Abstract][Full Text] [Related]
11. A Grading System for Invasive Pulmonary Adenocarcinoma: A Proposal From the International Association for the Study of Lung Cancer Pathology Committee.
Moreira AL; Ocampo PSS; Xia Y; Zhong H; Russell PA; Minami Y; Cooper WA; Yoshida A; Bubendorf L; Papotti M; Pelosi G; Lopez-Rios F; Kunitoki K; Ferrari-Light D; Sholl LM; Beasley MB; Borczuk A; Botling J; Brambilla E; Chen G; Chou TY; Chung JH; Dacic S; Jain D; Hirsch FR; Hwang D; Lantuejoul S; Lin D; Longshore JW; Motoi N; Noguchi M; Poleri C; Rekhtman N; Tsao MS; Thunnissen E; Travis WD; Yatabe Y; Roden AC; Daigneault JB; Wistuba II; Kerr KM; Pass H; Nicholson AG; Mino-Kenudson M
J Thorac Oncol; 2020 Oct; 15(10):1599-1610. PubMed ID: 32562873
[TBL] [Abstract][Full Text] [Related]
12. A CT-Based Radiomics Nomogram Combined with Clinic-Radiological Characteristics for Preoperative Prediction of the Novel IASLC Grading of Invasive Pulmonary Adenocarcinoma.
Yang Z; Cai Y; Chen Y; Ai Z; Chen F; Wang H; Han Q; Feng Q; Xiang Z
Acad Radiol; 2023 Sep; 30(9):1946-1961. PubMed ID: 36567145
[TBL] [Abstract][Full Text] [Related]
13. Gender-specific nomogram models to predict the prognosis of male and female lung adenocarcinoma patients: a population-based analysis.
Wen H; Lin X; Sun D
Ann Transl Med; 2021 Nov; 9(22):1654. PubMed ID: 34988163
[TBL] [Abstract][Full Text] [Related]
14. A Simplified Version of the IASLC Grading System for Invasive Pulmonary Adenocarcinomas With Improved Prognosis Discrimination.
Bossé Y; Gagné A; Althakfi WA; Orain M; Couture C; Trahan S; Pagé S; Joubert D; Fiset PO; Desmeules P; Joubert P
Am J Surg Pathol; 2023 Jun; 47(6):686-693. PubMed ID: 37032554
[TBL] [Abstract][Full Text] [Related]
15. Clinical implication of the 2020 International Association for the Study of Lung Cancer histologic grading in surgically resected pathologic stage 1 lung adenocarcinomas: Prognostic value and association with computed tomography characteristics.
Cho IS; Shim HS; Lee HJ; Suh YJ
Lung Cancer; 2023 Oct; 184():107345. PubMed ID: 37611496
[TBL] [Abstract][Full Text] [Related]
16. Micropapillary and solid components as high-grade patterns in IASLC grading system of lung adenocarcinoma: Clinical implications and management.
Mikubo M; Tamagawa S; Kondo Y; Hayashi S; Sonoda D; Naito M; Shiomi K; Ichinoe M; Satoh Y
Lung Cancer; 2024 Jan; 187():107445. PubMed ID: 38157805
[TBL] [Abstract][Full Text] [Related]
17. Proposal of a revised International Association for the Study of Lung Cancer grading system in pulmonary non-mucinous adenocarcinoma: The importance of the lepidic proportion.
Park BJ; Woo W; Cha YJ; Shim HS; Yang YH; Moon DH; Kim BJ; Kim HE; Kim DJ; Paik HC; Lee JG; Lee S; Lee CY
Lung Cancer; 2023 Jan; 175():1-8. PubMed ID: 36436241
[TBL] [Abstract][Full Text] [Related]
18. Tumor invasiveness as defined by the newly proposed IASLC/ATS/ERS classification has prognostic significance for pathologic stage IA lung adenocarcinoma and can be predicted by radiologic parameters.
Takahashi M; Shigematsu Y; Ohta M; Tokumasu H; Matsukura T; Hirai T
J Thorac Cardiovasc Surg; 2014 Jan; 147(1):54-9. PubMed ID: 24131786
[TBL] [Abstract][Full Text] [Related]
19. Prognostic impact of pattern-based grading system by the new IASLC/ATS/ERS classification in Asian patients with stage I lung adenocarcinoma.
Zhao ZR; Xi SY; Li W; Situ DR; Chen KM; Yang H; Su XD; Lin YB; Long H
Lung Cancer; 2015 Dec; 90(3):604-9. PubMed ID: 26547801
[TBL] [Abstract][Full Text] [Related]
20. Validation Study of the International Association for the Study of Lung Cancer Histologic Grading System of Invasive Lung Adenocarcinoma.
Rokutan-Kurata M; Yoshizawa A; Ueno K; Nakajima N; Terada K; Hamaji M; Sonobe M; Menju T; Date H; Morita S; Haga H
J Thorac Oncol; 2021 Oct; 16(10):1753-1758. PubMed ID: 33905897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
